TY - JOUR AU - Windecker, S. AU - Kolh, P. AU - Alfonso, F. PY - 2014 DA - 2014// TI - ESC/EACTS guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) JO - Eur Heart J VL - 35 UR - https://doi.org/10.1093/eurheartj/ehu298 DO - 10.1093/eurheartj/ehu298 ID - Windecker2014 ER - TY - JOUR AU - Eisenstein, E. L. AU - Anstrom, K. J. AU - Kong, D. F. PY - 2007 DA - 2007// TI - Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation JO - JAMA VL - 297 UR - https://doi.org/10.1001/jama.297.2.joc60179 DO - 10.1001/jama.297.2.joc60179 ID - Eisenstein2007 ER - TY - JOUR AU - Gwon, H. C. AU - Hahn, J. Y. AU - Park, K. W. PY - 2012 DA - 2012// TI - Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study JO - Circulation VL - 125 UR - https://doi.org/10.1161/CIRCULATIONAHA.111.059022 DO - 10.1161/CIRCULATIONAHA.111.059022 ID - Gwon2012 ER - TY - JOUR AU - Udell, J. A. AU - Bonaca, M. P. AU - Collet, J. P. PY - 2016 DA - 2016// TI - Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup ofpatients with previous myocardial infarction: a collaborative meta-analysis of randomized trials JO - Eur Heart J VL - 37 ID - Udell2016 ER - TY - JOUR AU - Navarese, E. P. AU - Andreotti, F. AU - Schulze, V. PY - 2015 DA - 2015// TI - Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials JO - BMJ VL - 350 UR - https://doi.org/10.1136/bmj.h1618 DO - 10.1136/bmj.h1618 ID - Navarese2015 ER - TY - JOUR AU - Thygesen, K. AU - Alpert, J. S. AU - White, H. D. PY - 2007 DA - 2007// TI - Universal definition of myocardial infarction JO - Circulation VL - 116 UR - https://doi.org/10.1161/CIRCULATIONAHA.107.187397 DO - 10.1161/CIRCULATIONAHA.107.187397 ID - Thygesen2007 ER - TY - JOUR AU - Cutlip, D. E. AU - Windecker, S. AU - Mehran, R. PY - 2007 DA - 2007// TI - Clinical end points in coronary stent trials: a case for standardized definitions JO - Circulation VL - 115 UR - https://doi.org/10.1161/CIRCULATIONAHA.106.685313 DO - 10.1161/CIRCULATIONAHA.106.685313 ID - Cutlip2007 ER - TY - JOUR PY - 1985 DA - 1985// TI - The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group JO - N Engl J Med VL - 312 ID - ref8 ER - TY - JOUR AU - Mehran, R. AU - Rao, S. V. AU - Bhatt, D. L. PY - 2011 DA - 2011// TI - Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium JO - Circulation VL - 123 UR - https://doi.org/10.1161/CIRCULATIONAHA.110.009449 DO - 10.1161/CIRCULATIONAHA.110.009449 ID - Mehran2011 ER - TY - JOUR AU - Higgins, J. P. AU - Thompson, S. G. AU - Deeks, J. J. PY - 2003 DA - 2003// TI - Measuring inconsistency in meta-analyses JO - BMJ VL - 327 UR - https://doi.org/10.1136/bmj.327.7414.557 DO - 10.1136/bmj.327.7414.557 ID - Higgins2003 ER - TY - JOUR AU - Liberati, A. AU - Altman, D. G. AU - Tetzlaff, J. PY - 2009 DA - 2009// TI - The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcareinterventions: explanation and elaboration JO - BMJ VL - 339 UR - https://doi.org/10.1136/bmj.b2700 DO - 10.1136/bmj.b2700 ID - Liberati2009 ER - TY - JOUR AU - Brar, S. S. AU - Kim, J. AU - Brar, S. K. PY - 2008 DA - 2008// TI - Long-term outcomes by clopidogrel duration and stent type in a diabetic population with de novo coronary artery lesions JO - J Am Coll Cardiol VL - 51 UR - https://doi.org/10.1016/j.jacc.2008.01.063 DO - 10.1016/j.jacc.2008.01.063 ID - Brar2008 ER - TY - JOUR AU - Han, Y. AU - Xu, B. AU - Xu, K. PY - 2016 DA - 2016// TI - Six versus 12 months of dual antiplatelet therapy after implantation of biodegradable polymer sirolimus-ElutingStent: randomized substudy of the I-LOVE-IT 2 trial JO - Circ Cardiovasc Interv VL - 9 UR - https://doi.org/10.1161/CIRCINTERVENTIONS.115.003145 DO - 10.1161/CIRCINTERVENTIONS.115.003145 ID - Han2016 ER - TY - JOUR AU - Schulz-Schüpke, S. AU - Byrne, R. A. AU - Berg, J. M. PY - 2015 DA - 2015// TI - Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual Antiplatelet Therapy After Drug-Eluting Stenting (ISAR-SAFE) Trial Investigators. ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy afterdrug-eluting stenting JO - Eur Heart J VL - 36 UR - https://doi.org/10.1093/eurheartj/ehu523 DO - 10.1093/eurheartj/ehu523 ID - Schulz-Schüpke2015 ER - TY - JOUR AU - Tarantini, G. AU - Nai Fovino, L. AU - Tellaroli, P. PY - 2016 DA - 2016// TI - Optimal duration of dual antiplatelet therapy after second-generation drug-eluting stent implantation in patientswith diabetes: The SECURITY (Second-Generation Drug-Eluting Stent Implantation Followed By Six- VersusTwelve-Month Dual Antiplatelet Therapy)-diabetes substudy JO - Int J Cardiol VL - 207 UR - https://doi.org/10.1016/j.ijcard.2016.01.068 DO - 10.1016/j.ijcard.2016.01.068 ID - Tarantini2016 ER - TY - JOUR AU - Collet, J. P. AU - Silvain, J. AU - Barthélémy, O. PY - 2014 DA - 2014// TI - Dual-antiplatelet treatment beyond 1 year after drug-eluting stent implantation (ARCTIC-Interruption): a randomised trial JO - Lancet VL - 384 UR - https://doi.org/10.1016/S0140-6736(14)60612-7 DO - 10.1016/S0140-6736(14)60612-7 ID - Collet2014 ER - TY - STD TI - Feres F, Costa RA, Abizaid A, OPTIMIZE TrialInvestigators, et al. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial. JAMA. 2013;310(23):2510–22. ID - ref17 ER - TY - JOUR AU - Kim, B. K. AU - Hong, M. K. AU - Shin, D. H. PY - 2012 DA - 2012// TI - A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation) JO - J Am Coll Cardiol VL - 60 UR - https://doi.org/10.1016/j.jacc.2012.06.043 DO - 10.1016/j.jacc.2012.06.043 ID - Kim2012 ER - TY - JOUR AU - Bonaca, M. P. AU - Bhatt, D. L. AU - Steg, P. G. AU - Storey, R. F. AU - Cohen, M. AU - Im, K. AU - Oude Ophuis, T. AU - Budaj, A. AU - Goto, S. AU - López-Sendón, J. AU - Diaz, R. AU - Dalby, A. AU - Werf, F. AU - Ardissino, D. AU - Montalescot, G. AU - Aylward, P. AU - Magnani, G. AU - Jensen, E. C. AU - Held, P. AU - Braunwald, E. AU - Sabatine, M. S. PY - 2016 DA - 2016// TI - Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y12 inhibitor withdrawal in patients withprior myocardial infarction: insights from PEGASUS-TIMI 54 JO - Eur Heart J VL - 37 UR - https://doi.org/10.1093/eurheartj/ehv531 DO - 10.1093/eurheartj/ehv531 ID - Bonaca2016 ER - TY - JOUR AU - Mauri, L. AU - Kereiakes, D. J. AU - Yeh, R. W. PY - 2014 DA - 2014// TI - Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents JO - N Engl J Med VL - 371 UR - https://doi.org/10.1056/NEJMoa1409312 DO - 10.1056/NEJMoa1409312 ID - Mauri2014 ER - TY - JOUR AU - Sardella, G. AU - Mancone, M. AU - Biondi-Zoccai, G. PY - 2012 DA - 2012// TI - Beneficial impact of prolonged dual antiplatelet therapy after drug-eluting stent implantation JO - J Interv Cardiol VL - 25 UR - https://doi.org/10.1111/j.1540-8183.2011.00713.x DO - 10.1111/j.1540-8183.2011.00713.x ID - Sardella2012 ER - TY - JOUR AU - Campo, G. AU - Tebaldi, M. PY - 2014 DA - 2014// TI - Short- versus long-term duration of dual antiplatelet therapy in patients treated for in-stent restenosis: a PRODIGY trial substudy (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) JO - J Am Coll Cardiol VL - 63 UR - https://doi.org/10.1016/j.jacc.2013.09.043 DO - 10.1016/j.jacc.2013.09.043 ID - Campo2014 ER - TY - JOUR AU - Thukkani, A. K. AU - Agrawal, K. AU - Prince, L. PY - 2015 DA - 2015// TI - Long-term outcomes in patients with diabetes mellitus related to prolonging clopidogrel more than 12 MonthsAfter coronary stenting JO - J Am Coll Cardiol VL - 66 UR - https://doi.org/10.1016/j.jacc.2015.06.1339 DO - 10.1016/j.jacc.2015.06.1339 ID - Thukkani2015 ER - TY - JOUR AU - Kandzari, D. E. AU - Barker, C. S. AU - Leon, M. B. AU - Mauri, L. AU - Wijns, W. AU - Fajadet, J. AU - Mehran, R. PY - 2011 DA - 2011// TI - Dual antiplatelet therapy duration and clinical outcomes following treatment with zotarolimus-eluting stents JO - JACC Cardiovasc Interv VL - 4 UR - https://doi.org/10.1016/j.jcin.2011.06.017 DO - 10.1016/j.jcin.2011.06.017 ID - Kandzari2011 ER - TY - JOUR AU - Gilard, M. AU - Barragan, P. AU - Noryani, A. A. PY - 2015 DA - 2015// TI - 6- versus 24-month dual antiplatelet therapy after implantation of drug-eluting stents in patients nonresistant toaspirin: the randomized, multicenter ITALIC trial JO - J Am Coll Cardiol VL - 65 UR - https://doi.org/10.1016/j.jacc.2014.11.008 DO - 10.1016/j.jacc.2014.11.008 ID - Gilard2015 ER - TY - JOUR AU - Colombo, A. AU - Chieffo, A. AU - Frasheri, A. PY - 2014 DA - 2014// TI - Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: the SECURITY randomized clinical trial JO - J Am Coll Cardiol VL - 64 UR - https://doi.org/10.1016/j.jacc.2014.09.008 DO - 10.1016/j.jacc.2014.09.008 ID - Colombo2014 ER - TY - JOUR AU - Lee, C. W. AU - Ahn, J. M. AU - Park, D. W. PY - 2014 DA - 2014// TI - Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trial JO - Circulation VL - 129 UR - https://doi.org/10.1161/CIRCULATIONAHA.113.003303 DO - 10.1161/CIRCULATIONAHA.113.003303 ID - Lee2014 ER - TY - JOUR AU - Park, S. J. AU - Park, D. W. AU - Kim, Y. H. PY - 2010 DA - 2010// TI - Duration of dual antiplatelet therapy after implantation of drug-eluting stents JO - N Engl J Med VL - 362 UR - https://doi.org/10.1056/NEJMoa1001266 DO - 10.1056/NEJMoa1001266 ID - Park2010 ER - TY - JOUR AU - Giustino, G. AU - Baber, U. AU - Sartori, S. PY - 2015 DA - 2015// TI - Duration of dual antiplatelet therapy after drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials JO - J Am Coll Cardiol VL - 65 UR - https://doi.org/10.1016/j.jacc.2015.01.039 DO - 10.1016/j.jacc.2015.01.039 ID - Giustino2015 ER - TY - JOUR AU - Yang, J. AU - Fan, Z. X. AU - Yang, C. J. AU - Wang, H. B. PY - 2015 DA - 2015// TI - A meta-analysis of randomized clinical trials comparing shorter (less or equal than 6 months) and longer (more or equal than 12 months) dual anti-platelet therapy following drug-eluting coronary stents JO - Iran Red Crescent Med J VL - 17 UR - https://doi.org/10.5812/ircmj.26904 DO - 10.5812/ircmj.26904 ID - Yang2015 ER - TY - JOUR AU - Valgimigli, M. AU - Campo, G. AU - Monti, M. PY - 2012 DA - 2012// TI - Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial JO - Circulation VL - 125 UR - https://doi.org/10.1161/CIRCULATIONAHA.111.071589 DO - 10.1161/CIRCULATIONAHA.111.071589 ID - Valgimigli2012 ER - TY - JOUR AU - Valgimigli, M. AU - Park, S. J. AU - Kim, H. S. PY - 2013 DA - 2013// TI - Benefits and risks of long-term duration of dual antiplatelet therapy after drug-eluting stenting: a meta-analysis of randomized trials JO - Int J Cardiol VL - 168 UR - https://doi.org/10.1016/j.ijcard.2013.03.047 DO - 10.1016/j.ijcard.2013.03.047 ID - Valgimigli2013 ER - TY - JOUR AU - Siddiqi, O. K. AU - Smoot, K. AU - Dufour, A. B. PY - 2015 DA - 2015// TI - Outcomes with prolonged clopidogrel therapy after coronary stenting in patients with chronic kidney disease JO - Heart VL - 101 UR - https://doi.org/10.1136/heartjnl-2014-307168 DO - 10.1136/heartjnl-2014-307168 ID - Siddiqi2015 ER - TY - JOUR AU - Fausto, F. AU - Ricardo Costa, D. PY - 2014 DA - 2014// TI - Impact pf short versus long term DAPT in patients with diabetes mellitus undergoing percutaneous intervention with endeavour zotarolimus eluting stents. A subanalysis of the large, prospective, randomized, multicenter OPTIMIZE trial JO - J Am Coll Cardiol VL - 63 ID - Fausto2014 ER - TY - JOUR AU - Silber, S. AU - Serruys, P. W. AU - Leon, M. B. PY - 2013 DA - 2013// TI - Clinical outcome of patients with and without diabetes mellitus after percutaneous coronary intervention with the resolute zotarolimus-eluting stent: 2-year results from the prospectively pooled analysis of the international global RESOLUTE program JO - JACC Cardiovasc Interv VL - 6 UR - https://doi.org/10.1016/j.jcin.2012.11.006 DO - 10.1016/j.jcin.2012.11.006 ID - Silber2013 ER - TY - JOUR AU - Park, K. W. AU - Lee, J. M. AU - Kang, S. H. PY - 2014 DA - 2014// TI - Everolimus-eluting Xience v/Promus versus zotarolimus-eluting resolute stents in patients with diabetes mellitus JO - JACC Cardiovasc Interv VL - 7 UR - https://doi.org/10.1016/j.jcin.2013.12.201 DO - 10.1016/j.jcin.2013.12.201 ID - Park2014 ER - TY - JOUR AU - Bundhun, P. K. AU - Li, N. AU - Chen, M. H. PY - 2015 DA - 2015// TI - Adverse cardiovascular outcomes between insulin-treated and non-insulin treated diabetic patients after percutaneous coronary intervention: a systematic review and meta-analysis JO - Cardiovasc Diabetol VL - 14 UR - https://doi.org/10.1186/s12933-015-0300-6 DO - 10.1186/s12933-015-0300-6 ID - Bundhun2015 ER - TY - JOUR AU - Tanzilli, G. AU - Greco, C. AU - Pelliccia, F. PY - 2009 DA - 2009// TI - Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study) JO - Am J Cardiol VL - 104 UR - https://doi.org/10.1016/j.amjcard.2009.07.002 DO - 10.1016/j.amjcard.2009.07.002 ID - Tanzilli2009 ER - TY - JOUR AU - Park, D. W. AU - Yun, S. C. AU - Lee, S. W. PY - 2008 DA - 2008// TI - Stent thrombosis, clinical events, and influence of prolonged clopidogrel use after placement of drug-elutingstent data from an observational cohort study of drug-eluting versus bare-metal stents JO - JACC Cardiovasc Interv VL - 1 UR - https://doi.org/10.1016/j.jcin.2008.06.011 DO - 10.1016/j.jcin.2008.06.011 ID - Park2008 ER - TY - JOUR AU - Campo, G. AU - Guastaroba, P. AU - Marzocchi, A. AU - Santarelli, A. AU - Varani, E. AU - Vignali, L. AU - Sangiorgio, P. AU - Tondi, S. AU - Serenelli, C. AU - Palma, R. AU - Saia, F. PY - 2013 DA - 2013// TI - Impact of COPD on long-term outcome after ST-segment elevation myocardial infarction receiving primary percutaneous coronary intervention JO - Chest VL - 144 UR - https://doi.org/10.1378/chest.12-2313 DO - 10.1378/chest.12-2313 ID - Campo2013 ER - TY - JOUR AU - Campo, G. AU - Pavasini, R. AU - Malagù, M. AU - Mascetti, S. AU - Biscaglia, S. AU - Ceconi, C. AU - Papi, A. AU - Contoli, M. PY - 2015 DA - 2015// TI - Chronic obstructive pulmonary disease and ischemic heart disease comorbidity: overview of mechanisms and clinical management JO - Cardiovasc Drugs Ther VL - 29 UR - https://doi.org/10.1007/s10557-014-6569-y DO - 10.1007/s10557-014-6569-y ID - Campo2015 ER -